Background and study aims Endoscopic retrograde cholangiopancreatography (ERCP) with a cytological sample is a valuable tool in the diagnosis of the aetiology of biliary stricture. Our aim was to evaluate whether a more dense Infinity Õ cytological brush is more sensitive in diagnosing malignancy than the regularly used brush. Patients and methods We recruited 60 patients with a biliary stricture suspicious for malignancy for a randomised controlled trial. Patients were randomly assigned to an Infinity Õ brush group (n ¼ 30) and a regularly used cytology brush group (n ¼ 30). All the patients had verified cancer during follow-up. Results Crossing the brush over the stricture was possible in each case without dilatation of the biliary duct. Brush cytology yield was good or excellent in 86.7% of cases with the Infinity Õ brush and 96.7% with the regular brush (p ¼ 0.161). The cytological sample showed clear malignancy in three patients (10.0%) in the Infinity Õ group and in 12 (40.0%) patients of the regular brush group (p ¼ 0.007). The cytological diagnosis was highly suspicious for malignancy or malignant in 14 patients (46.7%) in the Infinity Õ group and in 23 patients (76.7%) in the regular brush group (p ¼ 0.017). The result was benign in 10 patients (33.3%) in the Infinity Õ group and in four patients (13.6%) in the regular brush group (p ¼ 0.067). Conclusions With the standardised technique, the sensitivity of brush cytology is fairly good. The dense Infinity Õ brush does not show any advantage regarding sensitivity compared with the conventional cytology brush.
Introduction
When biliary stricture causes jaundice, it is customary to perform endoscopic retrograde cholangiopancreatography (ERCP) and to take brush cytology before placing a biliary stent. In case of malignancy, operative treatment and/or neoadjuvant therapy is often considered. In either situation, the definitive diagnosis of malignancy is a necessity. Brush cytology has a considerable weakness regarding sensitivity. Earlier results of conventional brush cytology have been within the range of 20% to 50%, mainly around 45% of sensitivity. [1] [2] [3] In a congress abstract, a relatively new Infinity Õ cytology brush had a promising sensitivity of 85% in detecting malignancy. [4] In another study, the Infinity Õ brush increased the cellularity of bile duct brushings compared with a standard brush. [5] In the prospective randomised study, we aimed to find out if the use of a dense Infinity Õ brush could increase sensitivity in detecting pancreaticobiliary malignancy compared with a regular cytology brush.
Patients and methods
1281 and 1218 ERCPs were performed at Helsinki University Central Hospital in 2013 and 2014 respectively. From September 2013 to October 2014, 60 patients with suspected malignant pancreaticobiliary stenosis who underwent ERCP with brushing were recruited. During the same time period, 424 patients were treated endoscopically for biliary stricture. The patients were randomised to an Infinity Õ group (Infinity Õ brush, U.S. Endoscopy, n ¼ 30) and to a regular brush group (RX Cytology Brush, Boston Scientific, Natick, MA, n ¼ 30) ( Table 1) .
The indication for ERCP in each case was to get access beyond the stricture in the biliary duct to achieve a cytology sample and to place a biliary stent. Exclusion criteria were patients aged below 18 years or, altered anatomy necessitating double-balloon ERCP. Following receipt of a signed informed consent, a sealed envelope was opened to determine group assignment. Patient characteristics are shown in Table 1 . The Helsinki University ethical committee approved the study. ERCPs were performed by four experienced operators (JH, LK, MU, OL), who each undertake around 300 ERCPs a year. One patient from the regular brush group was excluded because of inadequate follow-up information and was replaced by the next suitable patient. Of the patients, 53% were emergency cases. All patients received oral levofloxacillin 500 mg as a prophylactic antibiotic a maximum of 1 h prior to ERCP unless they were already receiving other antibiotic treatment. Diclofenac suppositorium was given to 88.3% of patients. Seven patients did not receive diclofenac due to renal insufficiency (n ¼ 5) or allergy (n ¼ 2).
The primary tools for primary biliary cannulation were a sphincterotome (Ultratome Õ , Boston Scientific, Miami, FL) and a 0.035-inch 260 cm long guide wire (Hydrosteer Õ , St. Jude Medical, Minnetonka, MN). If primary cannulation failed, further techniques (pancreatic sphincterotomy, needle knife precut) to gain access were used.
After gaining access to the biliary duct, the brush inside its sheath was passed above the stricture over the guidewire under fluoroscopic guidance. Leaving the bare brush above the stricture, the sheath was pulled back below the stricture. The brush was then withdrawn back into its sheath. This manoeuvre was repeated five times. The brush within its sheath was then pulled out as a single unit. The brush segment was cut from its wire and placed in 50% ethanol. Before that, 2 ml of cytology solution was aspirated into a syringe. The sheath of the brush was then flushed with the cytology solution into the same sample. The whole sample, brush and flushing sample, was transported to the cytology laboratory for routine processing. Cytospin slides were stained with Papanicolaou stain. A cell block was also prepared if there was enough material, and cell block sections were stained with haematoxylin and eosin. Two experienced pathologists (A.R., S.B.) evaluated the samples first independently and then made a consensus statement being blinded to the brush used and to the underlying disease. Representativeness of the cytological sample was assessed by using three categories: 1, excellent (abundant cellularity with well-preserved cellular morphology); 2, adequate (moderate cellularity); and 3, poor (scant cellularity). No non-representative samples were obtained. Cytological diagnosis was divided into five categories: 1, normal (absence of atypical cells); 2, benign (abnormal but non-malignant); 3, low suspicion of malignancy; 4, high suspicion of malignancy; and 5, malignant.
Plasma total amylase or pancreas specific amylase were measured before and 4-6 h after ERCP. If the patient stayed in hospital overnight, plasma amylase was checked the following morning. If a complication occurred, the patient remained in hospital until recovered.
The final diagnosis of malignancy was based on histology (biopsy or surgical specimen) of the lesion or metastasis. With the absence of a histological sample, radiologically verified infiltration of adjacent organs or metastases during the follow-up was considered as verified malignancy.
The main focus of the study was to evaluate the sensitivity of the brush cytology sample to detect malignancy between the two groups. The second focus was to evaluate the sufficiency of the cytological sample. The frequency of complications, i.e., post-ERCP pancreatitis (PEP), cholangitis, bleeding, and perforation, was recorded. PEP was defined as elevated plasma amylase three times or more above the upper reference limit, and the presence of abdominal pain persisting for 24 h after the procedure. Cholangitis was defined as fever requiring intravenous or intramuscular antibiotics within 2 d of ERCP. Bleeding was defined as a need for repeat endoscopy due to melena or transfusion of blood within 1 week of ERCP. Perforation was diagnosed as an extravasation of contrast during ERCP or retroperitoneal air in computed tomography following the procedure. The severity of the complications was defined according to consensus criteria. [6] Statistical analysis 
Results
The final diagnosis of all patients was malignant, 88.3% being pancreatic cancers (Table 1) . Malignancy was confirmed from surgical specimen (n ¼ 22) or by another histopathological sample from the tumour or metastasis (n ¼ 14). In the rest of the patients (n ¼ 24), malignancy was verified with radiology. The length of the follow-up of these 24 patients was median 11 months PEP was diagnosed in two patients (3.3%), one in each study group. Both PEP cases were treated conservatively. The first PEP patient (Infinity Õ group) stayed in hospital for 6 d and is considered thus as moderate. The other PEP patient was discharged 3 d after ERCP having mild disease. Post-sphincterotomy bleeding occurred in one patient (1.0%) and was treated endoscopically. One patient had guide-wire perforation but recovered uneventfully and was discharged from hospital the following day after ERCP. Hyperamylaesaemia without clinical signs of PEP was present in none in the Infinity Õ group and in 8 in the regular brush group (p ¼ 0.002). There were no cases of cholangitis nor perforation, nor were there any deaths within 30 d of ERCP. There were 17 deaths (28.3%) during the follow-up.
Discussion
The sensitivity of the regular brush was surprisingly good. One reason for that is most probably the policy to cut the whole brush into the sample and to flush the catheter to achieve adequate cellular yield. Another reason might be the patient selection since each patient had high suspicion of pancreaticobiliary malignancy. Anyhow, the result of the present study favours the use of the regular brush since the price of the Infinity Õ brush is considerably higher. There are studies showing that brush cytology is more sensitive in biliary duct cancer than in pancreatic cancer. In the present study, we only had four patients with biliary duct cancer and none of them showed clear malignancy in brush cytology. However, the present study was underpowered to draw any conclusions in differences in various malignancies causing biliary stricture.
Most patients with malignancy causing biliary stricture require ERCP with stenting. In ERCP, brush cytology is usually taken without increasing the rate of procedure related complications. The fact that there were statistically significantly more hyperamylaesemia cases in the regular brush group than in the Infinity Õ group in the present study is most probably coincidence and anyhow without clinical significance. If the definite diagnosis was possible to gain by ERCP and brush cytology, the decision when planning the appropriate therapy for the patients would be easier and would avoid the need for additional expensive invasive procedures for tumour tissue sample collection, such as endoscopic ultrasoundguided biopsy or cholangioscopy-assisted biopsy.
There are studies that show that advanced age [7] and a high bilirubin level are associated with increased sensitivity for detecting malignancy with brush cytology. [2] However, in the present study we could not find any relation between the accuracy of brush cytology and age, bilirubin level or even length of the stricture.
One shortcoming in this study was that the patients were not consecutive. We tried to avoid recruiting elderly patients in poor condition because the probability of having a definitive diagnosis of malignancy would have been obvious. In that way, only one recruited patient needed to be replaced by another.
Conclusions
The sensitivity of brush cytology to detect pancreaticobiliary malignancy is fairly good, when the brush is cut into the sample. The dense Infinity Õ brush is not superior regarding sensitivity compared with the regular cytology brush.
